clinical trial · NCT06075043
A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy
Cancer-Related AnemiaAND017
brief summary
The purpose of this study is to determine the safety and efficacy of various doses of AND017 after 6 weeks of treatment in subjects with anemia of cancer who are not receiving chemotherapy.
started
Dec 1, 2027
primary completion
May 1, 2028
completion
Aug 1, 2028
last updated
Feb 27, 2026
official title
A Multicenter, Randomized, Open-label Study of AND017 for the Treatment of Anemia of Cancer in Patients Not Receiving Chemotherapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol